Perioperative Outcomes of Rural-Dwelling Patients Undergoing Lung and Colon Cancer Operations in Rural Facilities.
1/5 보강
[BACKGROUND] Patients with cancer in rural areas often encounter significant barriers to accessing cancer care.
- p-value p < 0.001
APA
Egger ME, Jones T, et al. (2026). Perioperative Outcomes of Rural-Dwelling Patients Undergoing Lung and Colon Cancer Operations in Rural Facilities.. Journal of the American College of Surgeons, 242(4), 1032-1038. https://doi.org/10.1097/XCS.0000000000001781
MLA
Egger ME, et al.. "Perioperative Outcomes of Rural-Dwelling Patients Undergoing Lung and Colon Cancer Operations in Rural Facilities.." Journal of the American College of Surgeons, vol. 242, no. 4, 2026, pp. 1032-1038.
PMID
41670205 ↗
Abstract 한글 요약
[BACKGROUND] Patients with cancer in rural areas often encounter significant barriers to accessing cancer care. This study evaluated whether Medicare-aged patients can safely undergo lung and colon cancer surgery at their local rural hospital, limiting travel burden.
[STUDY DESIGN] Surveillance, Epidemiology, and End Results-Medicare files were used to identify patients with stage I to III colon and lung cancers. Patients residing in ZIP codes outside metropolitan statistical areas were defined as rural; facilities were similarly categorized. Rural patients undergoing elective colon or lung cancer surgery at rural vs urban facilities were compared. Unadjusted and risk-adjusted complication and mortality rates were compared using multivariate logistic regression. Driving distances between patients' residences and surgery facilities were calculated on the basis of ZIP codes.
[RESULTS] A total of 10,383 rural patients with colon cancer and 6,006 rural patients with lung cancer were identified. There were no clinically significant differences between rural and urban treatment groups in either colon or lung cohorts in terms of demographics or cancer stage; their comorbidity risks were similar. Mortality and complication rates were comparable across urban and rural facilities. Travel distance was significantly greater for patients treated at urban facilities than for those treated at rural facilities for patients with colon cancer (49 vs 16 miles, p < 0.001) and lung cancer (61 vs 35 miles, p < 0.001).
[CONCLUSIONS] Rural patients can achieve comparable short-term surgical outcomes for lung and colon cancer when treated at local rural facilities, thereby decreasing the travel burden of treatment at higher-volume urban facilities.
[STUDY DESIGN] Surveillance, Epidemiology, and End Results-Medicare files were used to identify patients with stage I to III colon and lung cancers. Patients residing in ZIP codes outside metropolitan statistical areas were defined as rural; facilities were similarly categorized. Rural patients undergoing elective colon or lung cancer surgery at rural vs urban facilities were compared. Unadjusted and risk-adjusted complication and mortality rates were compared using multivariate logistic regression. Driving distances between patients' residences and surgery facilities were calculated on the basis of ZIP codes.
[RESULTS] A total of 10,383 rural patients with colon cancer and 6,006 rural patients with lung cancer were identified. There were no clinically significant differences between rural and urban treatment groups in either colon or lung cohorts in terms of demographics or cancer stage; their comorbidity risks were similar. Mortality and complication rates were comparable across urban and rural facilities. Travel distance was significantly greater for patients treated at urban facilities than for those treated at rural facilities for patients with colon cancer (49 vs 16 miles, p < 0.001) and lung cancer (61 vs 35 miles, p < 0.001).
[CONCLUSIONS] Rural patients can achieve comparable short-term surgical outcomes for lung and colon cancer when treated at local rural facilities, thereby decreasing the travel burden of treatment at higher-volume urban facilities.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.